Insulin glargine and Wellbaby DHA
Determining the interaction of Insulin glargine and Wellbaby DHA and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin Glargine
Generic Name: omega-3 polyunsaturated fatty acids
Brand name: Proferrin-ES
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine-Wellbutrin
- Insulin glargine-Wellbutrin SR
- Insulin glargine-Wellbutrin Tablets
- Insulin glargine-Wellbutrin XL
- Insulin glargine-Wellcovorin
- Insulin glargine-Wera
- Wellbaby DHA-Insulin Glargine (U-100) Cartridge Systems and Pens
- Wellbaby DHA-Insulin Glargine (U-100) Vials
- Wellbaby DHA-Insulin Glargine (U-300) Pens
- Wellbaby DHA-Insulin glargine and lixisenatide
- Wellbaby DHA-Insulin glargine and lixisenatide Subcutaneous
- Wellbaby DHA-Insulin glargine, recombinant Subcutaneous